Oncoclínicas do Brasil Serviços Médicos (ONCO3) investor relations material

Executive summary

• Faced significant operational and financial headwinds in Q2 2026, including a drug/medication supply crisis, liquidity constraints, and cash flow pressures, but maintained care quality and advanced restructuring and cost optimization initiatives.

• Implemented a R$150 million private financing agreement to stabilize medicine supply and engaged in creditor negotiations to realign debt amortization and strengthen financial capacity.

• Non-recurring accounting adjustments, including credit loss provisions, impairments, and contract termination penalties, significantly affected results.

• Entered judicial recovery in July 2026 to restructure approximately R$5.1 billion in financial debt, with all debt reclassified as short-term due to covenant breaches.

• Continued focus on sustainable growth, profitability, and transparent communication with the market.

Financial highlights

• Gross revenue for Q2 2026 was R$1,227.6 million, down 25.9% year-over-year; net revenue was R$1,047.7 million, down 28.5% year-over-year, mainly due to medication shortages and asset sales.

• Adjusted EBITDA for Q2 2026 was R$34.3 million (margin 9.5% excluding PCLD), but only R$34.2 million (margin 3.3%) including all effects; net loss for the quarter was R$475.7 million, with net loss ex-hospitals at R$425 million.

• Gross margin, excluding non-recurring effects, was 27.2%; accounting gross margin was 21.9%–22.2%.

• Cash flow from operations was positive at R$158.4 million, mainly due to renegotiated supplier terms and normalization of receivables.

• Net debt at quarter-end was R$3.4 billion, with total debt at R$3,686.7 million and cash position at R$129.0–R$160.9 million.

Outlook and guidance

• Recovery is expected to be gradual, with ongoing discipline in executing the restructuring plan, cost optimization, and asset divestitures to restore profitability and liquidity.

• Management remains focused on operational turnaround, considering inorganic initiatives and further operational adjustments.

• Judicial recovery aims to provide a stable environment for debt renegotiation and operational continuity.